GlassScriptPhysician profile
Garrett Ossolinski
NPI 1760269344
$6,804.93
in general payments reported to CMS, 2019-2025
7 companies · $6,033 in 2025
The $6,033 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $771 · 2025: $6,033.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,958 · Food and Beverage: $1,555 · Travel and Lodging: $1,194 · Education: $98.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,958.33 |
| Food and Beverage | $1,554.76 |
| Travel and Lodging | $1,193.84 |
| Education | $98.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $4,111.93 | 2025 | Stratafix, Dermabond Prineo, Vistaseal |
| Medical Device Business Services, INC. | $1,646.15 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $515.76 | 2024-2025 | Persona, Avenir, Mymobility Platform |
| Davol INC. | $247.40 | 2024-2025 | Arista, Surgiphor, Channel Drain |
| Heron Therapeutics, INC. | $119.90 | 2024 | Zynrelef |
| Linkbio Corp | $110.66 | 2024 | |
| Orthalign INC | $53.13 | 2024 | Orthalign Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garrett Ossolinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.